Skip to main content
. 2022 Feb 15;5:132. doi: 10.1038/s42003-022-03078-5

Fig. 6. Cholesterol efflux from macrophages of individuals harboring the Jak2V617F mutation.

Fig. 6

a Cholesterol efflux from blood monocyte-derived macrophages of healthy donors measured at baseline and after treatment with AG490, TO901317, or both (n = 8/group), b and from individuals harboring the Jak2V617F mutation at baseline and after treatment with AG490 (n = 8–17/group). Statistical analysis: one-way ANOVA with Tukey’s multiple comparisons were performed. Data are presented as the mean ± SEM, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.